Caplin Point Laboratories board approves un-audited financial results

05 Nov 2020 Evaluate

Caplin Point Laboratories has informed that the Board of Directors of the Company at their meeting held today (November 05, 2020) considered and approved the Un-audited Financial Results for the quarter/ half year ended September 30, 2020. Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company enclosed Un-audited Financial Results (Consolidated and Standalone) for the quarter/ half year ended September 30, 2020; Limited Review Report (Consolidated and Standalone) for Un-audited Financial Results; Press Release on the above Un-audited Financial Results; and Investors Presentation.

The above information is a part of company’s filings submitted to BSE.

Caplin Point Lab Share Price

1505.15 -52.05 (-3.34%)
30-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1757.35
Dr. Reddys Lab 1254.65
Cipla 1223.05
Zydus Lifesciences 871.20
Lupin 2312.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×